H2U Corporation
TTWSE:783517.05
TWD
-0.55
(-3.12%)
ISIN
TW0007835001
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
TWD
•
in mil. unless spec.Working Capital
TWD
•
in mil. unless spec.Growth Rates
TWD
•
in mil. unless spec.Quarterly Revenue
TWD
•
in mil. unless spec.Quarterly Earnings Per Share
TWD
•
in mil. unless spec.Quarterly Dividends Per Share
TWD
•
in mil. unless spec.Company Description
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- New Taipei City Taiwan
- IPO Date
- Jul 24, 2026
- Website
- h2u.io
- Similar Companies
- Business
- H2U Corporation operates as a digital health technology and data platform company in Taiwan and internationally. The company provides artificial intelligence (AI)-powered health data analytics, enterprise wellness solutions, medical examination management systems, and digital health media platforms. Its core products and services include H2U eXamine, a cloud-based health examination information system utilized by medical institutions and diagnostic clinics for health screening data management and workflow automation; H2U eXpert, a business-to-business corporate health management solution delivering occupational wellness tracking, employee health record administration, and corporate ESG sustainability compliance reporting; H2U pano, a flagship integrated digital health ecosystem platform leveraging proprietary AI engines and large language models to deliver personalized health risk assessments, lifestyle tracking, and precision health guidance; digital media and community platforms comprising Everyday Health, an online medical journalism and wellness educational portal, alongside Sports Note and Hiking Biji, which provide athletic community networking, sports technology, and athletic event management solutions; and specialized e-commerce operations distributing curated nutritional supplements, functional food products, and health-related goods. Originally founded in December 2013 as an internal corporate health initiative spun off from Foxconn Technology Group, H2U Corporation is headquartered in New Taipei City, Taiwan. In recent developments, the company completed its initial public offering and listed its shares on the Taiwan Innovation Board of the Taiwan Stock Exchange (TWSE: 7835) in July 2026. The company previously completed a Series B funding round exceeding USD 10 million led by South Korea-based clinical laboratory specialist SCL Healthcare Group via Innotherapy Inc., alongside strategic investments from Standard Foods, WeLeader Bio, and GrandTech C.G. Systems. Under its strategic alliance with SCL, H2U Corporation is expanding its digital health and checkup platforms into South Korea while integrating international diagnostic solutions into Taiwan, and continuing to explore regional growth across Japan and Southeast Asia. The company has also upgraded its AI-powered H2U pano platform and partnered with national healthcare initiatives to support preventative medicine, chronic disease management, and digital health reward ecosystems.